Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.
Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.
Address: Top Floor, 111 Rathmines Road Lr, Dublin 6
Tel: 353 (01) 441 0024
GreenCross Publishing is owned by Graham Cooke.
You are reading 1 of 2 free-access articles allowed for 30 days
Further screening resources required immediately to help combat carbapenemase-producing Enterobacteriaceae (CPE) have not yet been provided by the Department of Health for 2019, the Medical Independent (MI) understands.
At press time, the HSE and Department were due to discuss some additional funding. To date, MI understands the Department had committed to around €2 million for 2019, which represents the full-year costs of new posts agreed in 2018.
In June 2018, the HSE warned the Department that the National Lead for healthcare-associated infection (HCAI) and antimicrobial resistance (AMR) Prof Martin Cormican advised of an “urgent need to progress full implementation of guidance on CPE screening if we are to respond effectively to the CPE public health emergency”.
As part of the 2019 estimates process, the HSE sought resources to carry out the required level of screening, with €3.1 million requested for an additional 15 laboratory posts (€0.595 million) and laboratory supplies for testing (€2.5 million).
However, the requested funding for screening has not yet been provided. In June, the then HSE interim Director General Mr John Connaghan informed Chief Medical Officer Dr Tony Holohan that “the €2 million allocation is clearly not sufficient to cover the full costs of immediate implementation of the CPE Screening Guidelines”.
He wrote that Prof Cormican’s advised that “delay in implementing screening guidance materially increases the risk that CPE will become irreversibly endemic in our healthcare system”.
It is understood the HSE considers resources for screening, managing patients with CPE, infection prevention and control staff deficits, and healthcare infrastructure as the key elements of combatting CPE.
In January, The Irish Times reported that the Government had approved €20 million for a three-year plan to tackle CPE and quoted Minister for Health Simon Harris.
However, when contacted by MI, the Department did not confirm this funding. A spokesperson said it allocated dedicated funding in 2018 and work was underway to “prioritise work programmes and allocate funding for 2019”.
Speaking to MI on 23 February, Prof Cormican said some “very good progress” was made in 2018. However, he said “we will need to up the game quite a bit in 2019 and 2020 if we are actually going to try and put this back in the box”.
CPE was declared a public health emergency by Minister Harris in October 2017.
The HSE is still unable to confirm a date for the publication of the long-delayed National...
The HSE has not sought funding from the Department of Health to meet the community service...
The ICGP is examining alternative pathways for entry into general practice training as part of efforts...
In December, the HSE released part of an external review into the case of 'Brandon', a...
The evidence on doctor burnout “should scare us and concern us”, the Director of the RCSI...
A review of public health governance structures and addressing “longstanding” IT infrastructure...
Leave a Reply
You must be logged in to post a comment.